Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

PERKING THINGS UP AT ORPHAN MEDICAL.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • نبذة مختصرة :
      Discusses the development of the narcolepsy drug Xyrem by Orphan Medical (ORPH) and the ramifications of its release on the company's stock. Decision of the United States Food and Drug Administration to grant the drug priority review status; Opinion of Michael Scheffery, a general partner at OrbiMed Advisors, that the company's stock is a good investment.